Supported by a team of world-renowned leaders in the field of autoimmune neurology, Mayo Clinic Laboratories’ testing for immune-mediated neurological disorders is unparalleled. Driven by ongoing discoveries about the role of autoantibody biomarkers in autoimmune neurologic disease, our lab continually validates novel autoantibody profiles that inform clinical decision-making. With evaluations that span the spectrum of autoimmune neurological disorders, our testing enables insights on diagnosis, prognosis, disease management, and treatment efficacy.
Videos, webinars, podcasts, and Hot Topics
Communique, Case Study, and Patient Spotlight